TABLE 1.
Correlations | R2 |
GSH/GSSG in brain vs. OH8dG level in brain | 0.36 |
OH8dG level in brain vs. OH8dG level in WBC | 0.90* |
Oxidative DNA damage (fpg comet) in brain vs. oxidative DNA damage (fpg comet) in WBC | 0.91* |
Oxidative DNA damage (fpg comet) in WBC vs. ROS in plasma | 0.98* |
OH8dG level in brain vs. ROS in plasma | 0.97* |
Adjusted OH8dG level in braina vs. tumor incidenceb | 0.92* |
Adjusted oxidative DNA damage in brain (comet assay)a vs. tumor incidenceb | 0.93* |
Adjusted OH8dG level in WBCa vs. tumor incidenceb | 0.82* |
Adjusted oxidative DNA damage in WBC (comet assay)a vs. tumor incidenceb | 0.90* |
Note. Data were analyzed by linear regression. *Statistically significant (p < 0.05, ANOVA).
Data were normalized with doses used in tumor incidence bioassay.
Tumor incidence data were from Quast and Friedman (2002).